Literature DB >> 34436711

The relationship between sleep disorders, anxiety, depression, and cognitive function with restless legs syndrome (RLS) in the elderly.

Yuan Xu1,2, Hongbin Wen1,2, Jie Li1,2, Jing Yang1, Kai Luo3, Liying Chang1,2.   

Abstract

OBJECTIVES: Restless legs syndrome (RLS) has a significant effect on sleep and quality of life. Delays in diagnosis and treatment are frequent due to a lack of awareness. In this study, a clinical analysis was performed to examine the relationship between sleep, mood, and cognitive function in RLS.
METHODS: According to the Pittsburgh Sleep Quality Index score (PSQI), patients with RLS were divided into a sleep disorders group (SD, PSQI > 7) and non-sleep disorders group (NSD, PSQI ≤ 7). Healthy controls were selected as a control group matched for age, cultural background, and marital status. We compared differences between the three groups using the Hamilton Anxiety Scale (HAMA), Hamilton Depression (HAMD), Mini-Mental State Examination (MMSE), and Montreal Cognitive Assessment (MoCA). The SD and NSD groups were also assessed with the Restless Leg Syndrome Rating Scale (RLSRS) and the severity of RLS between the two groups was compared. The analysis used t-test, ANOVA, and Pearson correlation.
RESULTS: (1) Among the 54 RLS patients, 30 people in the control group, 35 patients with sleep disorders (SD, 65%), and 19 patients without sleep disorders (NSD, 35%), there were no significant differences in age, educational level, marital status, or trauma history. (2) The comparison results of the case group (SD and NSD) and the control group showed highly significant differences (P < 0.01) in the PSQI-HAMA-HAMD score but no significant differences between the NSD group, the SD group, and the control group in MMSE score. There was no difference between the NSD group and the control group in the MoCA, but a significant difference (P < 0.05) between the SD group and the control group was found. (3) The comparison between the NSD and the SD groups revealed significant differences in the RLSRS, HAMA, and HAMD scores (P < 0.05), but there were no statistical differences (P > 0.05) between two groups on MMSE and MoCA score. (4) Correlation and regression showed that there was a linear correlation between PSQI scores and RLSRS and HAMD scores in patients with RLS (P < 0.05). The regression equation was PSQI =  - 2.393 + 0.494 RLSRS + 0.170 HAMD.
CONCLUSIONS: RLS patients were prone to sleep disorders, anxiety, and depression. Sleep disorders increased with the severity of the RLS and had some influence on the patient's cognitive function. Sleep disorders were closely related to RLSRS and HAMD.
© 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  Anxiety; Cognitive function; Depression; Restless legs syndrome; Sleep disorder

Mesh:

Year:  2021        PMID: 34436711     DOI: 10.1007/s11325-021-02477-y

Source DB:  PubMed          Journal:  Sleep Breath        ISSN: 1520-9512            Impact factor:   2.655


  33 in total

Review 1.  Restless legs syndrome.

Authors:  Karl Ekbom; J Ulfberg
Journal:  J Intern Med       Date:  2009-11       Impact factor: 8.989

2.  Attention-Deficit Hyperactivity and Obsessive-Compulsive Symptoms in Adult Patients With Primary Restless Legs Syndrome: Different Phenotypes of the Same Disease?

Authors:  Imad Ghorayeb; Ashley Gamas; Zoé Mazurie; Willy Mayo
Journal:  Behav Sleep Med       Date:  2017-05-30       Impact factor: 2.964

3.  Depressive disorders in restless legs syndrome: epidemiology, pathophysiology and management.

Authors:  Magdolna Hornyak
Journal:  CNS Drugs       Date:  2010-02       Impact factor: 5.749

4.  Serum Glycomics Profiling of Patients with Primary Restless Legs Syndrome Using LC-MS/MS.

Authors:  Xue Dong; Stefania Mondello; Firas Kobeissy; Raffaele Ferri; Yehia Mechref
Journal:  J Proteome Res       Date:  2020-06-17       Impact factor: 4.466

5.  Restless Legs Syndrome: Psychiatric Comorbidities Are More Important Than Neuroticism.

Authors:  Ellen Trautmann; Antonia Barke; Johanna U Frisch; Anna-Lena Schmidt; Fabia Kunert; Monica Canelo; Friederike Sixel-Döring; Claudia Trenkwalder
Journal:  Behav Sleep Med       Date:  2014-06-19       Impact factor: 2.964

Review 6.  Restless legs syndrome in the older adult: diagnosis and management.

Authors:  Shawn A Milligan; Andrew L Chesson
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

7.  Practice guideline summary: Treatment of restless legs syndrome in adults: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Authors:  John W Winkelman; Melissa J Armstrong; Richard P Allen; K Ray Chaudhuri; William Ondo; Claudia Trenkwalder; Phyllis C Zee; Gary S Gronseth; David Gloss; Theresa Zesiewicz
Journal:  Neurology       Date:  2016-11-16       Impact factor: 9.910

8.  Prevalence and Risk Factors of Restless Legs Syndrome in Hemodialysis Patients.

Authors:  Li-Yan Zhang; Xiao-Yang Ma; Jun Lin; Wen-Hu Liu; Wang Guo; Le Yin; Shi-Xiang Wang; Xia Li; Jing Li; Li-Li Jin; Ze-Long Tian; Yi-Tong Du; Hou-Zhen Tuo
Journal:  Nat Sci Sleep       Date:  2020-01-14

9.  Effects of short- and long-term variations in RLS severity on perceived health status - the COR-study.

Authors:  Andrea Fuhs; Dunya Bentama; Rafael Antkowiak; Johannes Mathis; Claudia Trenkwalder; Klaus Berger
Journal:  PLoS One       Date:  2014-04-17       Impact factor: 3.240

10.  Relation of serum hepcidin levels and restless legs syndrome in chronic hemodialysis patients.

Authors:  Ahmet Tufekci; Ekrem Kara
Journal:  Sleep Breath       Date:  2020-10-07       Impact factor: 2.816

View more
  2 in total

1.  Association between thyroid function and disease severity in restless legs syndrome.

Authors:  Chaofan Geng; Zhenzhen Yang; Xiumei Kong; Pengfei Xu; Hongju Zhang
Journal:  Front Neurol       Date:  2022-08-12       Impact factor: 4.086

2.  Correlation between vitamin D and poor sleep status in restless legs syndrome.

Authors:  Chaofan Geng; Zhenzhen Yang; Xiumei Kong; Pengfei Xu; Hongju Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-15       Impact factor: 6.055

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.